Researchers at the Icahn School of Medicine at Mount Sinai in New York City have unveiled groundbreaking findings that could revolutionize the management of inflammatory bowel disease (IBD). Led by Dr. Robert Hirten, the study discovered that wearable devices can predict IBD flares up to seven weeks in advance. Conducted between December 2021 and June 2023, this research involved participants who wore wearable devices for at least eight hours a day and completed regular questionnaires, offering unprecedented insights into early flare detection.
The study's primary goal was to explore whether wearable technology could provide a predictive edge in managing IBD, an often unpredictable condition. Participants, who could remain involved in the study for as long as they wished, were required to respond to questionnaires a minimum of four times a week. The data collected revealed that these devices could indeed identify physiological markers associated with impending flares well before traditional symptoms appeared.
“We find that metrics that relate to physiological activity collected from wearables are able to differentiate whether inflammation is present in the body. These types of changes, however, are likely not specific to one disease. Rather, they reflect and are altered by inflammation in the body. Therefore, our findings will likely be useful in the setting of chronic inflammatory diseases, and may help with the identification of inflammation developing from these conditions.” – Robert Hirten, MD
Dr. Hirten, who serves as Clinical Director of the Hasso Plattner Institute for Digital Health and an Associate Professor of Medicine, emphasized the potential for these findings to extend beyond IBD. The study suggests that the physiological changes detected by wearable devices might be applicable to a broader range of chronic inflammatory diseases. This discovery opens new avenues for early intervention and personalized treatment strategies.
The unique aspect of this study is its reliance on wearable technology combined with artificial intelligence. The team aims to develop advanced deep learning algorithms to analyze the data collected from wearables. These algorithms could then predict the likelihood of an IBD flare, providing patients and healthcare providers with crucial lead time to adjust treatment plans.
“Our goal is to develop deep learning algorithms (AI algorithms) that pick up these changes in wearable measured signatures that we have described, and determine the probability or chance that a person will flare,” – Robert Hirten, MD
IBD flares often catch patients off guard, causing significant discomfort and disruption. Co-author Bedford highlighted that many patients experience abdominal disturbances immediately before a flare occurs, making early detection even more valuable.
“Patients really don’t sense it until the flare is upon them. They may have some abdominal disturbances before they actually have a flare, but that’s usually immediately just before it is about to occur,” – Bedford
With the insights provided by wearables, patients might adjust their medication or diet preemptively or even conduct lab tests to confirm an imminent flare.
“They may be able to take some changes in what they’re doing before that occurs, whether that’s an adjustment of medication or an adjustment of diet,” – Bedford
“Maybe even getting a preemptory lab test, which again will affirm that a flare is about to occur.” – Bedford
Leave a Reply